GLP-1 Weight Loss Before Surgery: Keep the Muscle You Will Need to Recover

Medically reviewed by Chad M. Ferguson, MD, on October 18, 2026.

Why your surgeon cares what kind of weight you lose

Many people start a GLP-1 medication because a surgeon has asked them to lose weight before an operation. Hip and knee replacement are common examples. Joint replacement surgeons often treat a body mass index of 40 or higher as a high-risk threshold for elective surgery, although the field still debates whether any fixed cutoff is fair to patients.

The medicines are effective at moving the scale. In the STEP 1 trial, adults taking semaglutide 2.4 mg once weekly lost an average of 14.9 percent of their body weight over 68 weeks, compared with 2.4 percent on placebo. In SURMOUNT-1, adults taking the highest dose of tirzepatide (15 mg weekly) lost an average of 20.9 percent over 72 weeks, compared with 3.1 percent on placebo. Semaglutide is sold under the brand names Ozempic and Wegovy, and tirzepatide is sold as Mounjaro and Zepbound.

A surgeon, however, does not operate on a number. After surgery you rehabilitate with your muscles, and the quadriceps in particular are central to standing, walking and climbing stairs after a hip or knee operation. The goal before surgery is therefore to lose fat while keeping as much muscle and strength as you can.

What the trials measured, stated precisely

You may have read that 30 to 40 percent of the weight lost on these medicines is muscle. That figure overstates what the trials found, because the scans measured lean mass, and lean mass is not the same thing as muscle.

• In a STEP 1 subgroup that underwent DXA body composition scans, about 38 percent of the weight lost was lean mass and about 62 percent was fat.
• In the SURMOUNT-1 DXA substudy of 160 participants, about 75 percent of the weight lost was fat and about 25 percent was lean mass. The placebo group, which lost far less weight, showed the same proportions.

Lean mass includes muscle, but it also includes organs, bone, body water and the water held inside fat tissue. Muscle makes up roughly half of lean mass. On that basis, a joint advisory from four obesity and nutrition societies estimated that muscle accounted for about 20 percent of the weight lost in STEP 1. Studies using MRI suggest that the reduction in muscle volume on these medicines is broadly in line with what weight loss of that size would predict, and that the fat stored inside muscle tends to decrease.

The accurate summary is that these medicines cause some loss of muscle, as any large weight loss does. That loss is smaller than the popular figure suggests. The steps below are reasonable strategies to support muscle while you lose weight, although direct evidence in people taking GLP-1 medications is still limited.

Why the weeks around surgery matter

Muscle is lost quickly when a limb stops working. In a study of healthy young men whose knee was immobilized for five days, the cross-sectional area of the thigh muscle fell by 3.5 percent and leg strength fell by 9 percent. After total knee replacement, quadriceps strength measured about four weeks after surgery was 62 percent lower than before the operation, and the cross-sectional area of the muscle was 10 percent smaller. Most of that early weakness came from a reduced ability of the nervous system to activate the muscle, but loss of muscle tissue also contributed.

Strength commonly declines after a major orthopaedic operation. A patient who has also lost muscle during months of rapid weight loss starts that recovery with less in reserve. Protecting muscle before surgery is one of the few parts of recovery that you can control in advance.

Four steps that protect muscle during GLP-1 weight loss

1. Train against resistance

Resistance training is a well-established way to protect muscle during weight loss. In a trial of 160 older adults with obesity who lost about 9 percent of their body weight, lean mass fell by 2 to 3 percent in the groups that did resistance training or combined resistance and aerobic training, compared with 5 percent in the group that did aerobic training alone. Strength rose by 18 to 19 percent in the groups that included resistance training and by 4 percent in the aerobic group.

A painful hip or knee does not rule out strength training, but it changes the program. A physical therapist can build a program around the joint that needs surgery, and your surgeon can tell you which movements to avoid. Machines, resistance bands and seated exercises can train the large muscles of the legs without loading a painful joint the way that running or deep squats do.

2. Eat enough protein, and spread it across the day

A GLP-1 medication lowers appetite, and protein is often the first part of the diet to suffer. The joint advisory notes that the recommended dietary allowance is 0.8 g of protein per kilogram of body weight per day, and that targets of 1.2 to 1.6 g per kilogram have been proposed during active weight loss. For people with obesity, these targets are often calculated on an adjusted body weight rather than actual weight, because actual weight overestimates the need. The same advisory recommends against prolonged intake above 2 g per kilogram per day. Your provider or a registered dietitian can calculate a target for you, and anyone with kidney disease should set that target with a physician.

Distribution matters as well. In a small crossover study, healthy adults who ate about 30 g of protein at each of three meals had 25 percent higher muscle protein synthesis over 24 hours than when they ate the same total amount of protein weighted toward dinner. On a GLP-1 medication, a practical rule is to eat the protein portion of each meal first, before you feel full.

A protein shake can close the gap on days when appetite is low. In a randomized trial in older women, whey protein stimulated muscle protein synthesis while collagen protein did not raise it significantly. Truthe Nutrition Blend provides 20 g of whey protein in each 30 g scoop.

3. Consider the supplements with evidence behind them

Two supplements have reasonable evidence for supporting muscle, and a third ingredient explains how one of them works.

• Creatine monohydrate. In a meta-analysis of 357 older adults doing resistance training, adding creatine increased fat-free mass and some measures of strength more than training alone.
• HMB (beta-hydroxy-beta-methylbutyrate). In a small randomized trial, healthy older adults on 10 days of strict bed rest lost an average of 2.05 kg of lean mass on placebo, while the group taking 3 g of HMB a day showed no significant loss. The authors stated that a larger trial is needed to confirm the result.
• Leucine. Leucine is an essential amino acid, and the body produces HMB when it breaks leucine down.

MyoStim combines these ingredients in one stick: 3 g of creatine monohydrate, 2 g of HMB, 1 g of L-leucine and 5 g of collagen peptides, with 1,000 IU of vitamin D and 290 mg of calcium. The label serving is one stick a day, and each box holds 14 sticks. One stick provides less HMB than the 3 g a day used in the bed rest trial. MyoStim is sold as part of the Recovery Bundle and the Complete Nutrition kit.

4. Plan the medication around the operation with your team

Stopping a GLP-1 medication has consequences. In the STEP 1 extension, participants who stopped semaglutide regained 11.6 of the 17.3 percentage points of body weight they had lost within one year, which is about two thirds. Whether you hold the medication before surgery, and when you restart it, is a decision for your surgeon, your anesthesiologist and your prescribing provider together. Our article on surgery while taking a GLP-1 lists the questions to ask.

Measure strength, not only weight

The scale cannot tell fat from muscle. Ask your provider whether a body composition scan makes sense for you. You can also track a simple measure of strength at home, such as the number of times you can rise from a chair in 30 seconds without using your arms. If that number falls while your weight falls, tell your provider and your physical therapist.

Questions to bring to your surgeon and prescribing provider

• What weight or body mass index do you need me to reach before surgery, and by when?
• How quickly should I lose that weight, given that faster weight loss can cost more lean mass?
• Can I see a physical therapist before surgery for a strength program built around my joint?
• What daily protein target should I aim for?
• Should I hold my GLP-1 medication before surgery, and who will tell me when to restart it?

Where Truthe fits

Truthe was founded by surgeons to support patients through the nutrition side of surgery. Our guide to nutrition around surgery covers protein, vitamins and timing in the weeks before and after an operation. If you and a licensed provider decide that a GLP-1 medication belongs in your plan, the Truthe Rx LEAN program offers semaglutide or tirzepatide, and the Truthe Rx MICRODOSING program offers a lower-dose approach. Truthe does not prescribe, and an independent licensed provider decides whether a prescription is appropriate for you.

Disclaimer: This content is for educational purposes only and is not medical advice. Talk with your surgeon and a licensed healthcare provider about your situation. Statements about dietary supplements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Sources

1. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989-1002. doi.org/10.1056/NEJMoa2032183
2. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216. doi.org/10.1056/NEJMoa2206038
3. Look M, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes Obes Metab. 2025;27:2720-2729. pubmed.ncbi.nlm.nih.gov/39996356
4. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obes Pillars. 2025;15:100181. doi.org/10.1016/j.obpill.2025.100181
5. Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab. 2024;26 Suppl 4:16-27. doi.org/10.1111/dom.15728
6. Akram F, et al. Comorbidities in total hip and knee arthroplasty patients: when is it okay to say no? Orthop Clin North Am. 2025;56:1-12. doi.org/10.1016/j.ocl.2024.01.003
7. Dirks ML, et al. Neuromuscular electrical stimulation prevents muscle disuse atrophy during leg immobilization in humans. Acta Physiol (Oxf). 2014;210:628-641. doi.org/10.1111/apha.12200
8. Mizner RL, et al. Early quadriceps strength loss after total knee arthroplasty: the contributions of muscle atrophy and failure of voluntary muscle activation. J Bone Joint Surg Am. 2005;87:1047-1053. doi.org/10.2106/JBJS.D.01992
9. Villareal DT, et al. Aerobic or resistance exercise, or both, in dieting obese older adults. N Engl J Med. 2017;376:1943-1955. doi.org/10.1056/NEJMoa1616338
10. Mamerow MM, et al. Dietary protein distribution positively influences 24-h muscle protein synthesis in healthy adults. J Nutr. 2014;144:876-880. doi.org/10.3945/jn.113.185280
11. Oikawa SY, et al. Whey protein but not collagen peptides stimulate acute and longer-term muscle protein synthesis with and without resistance exercise in healthy older women. Am J Clin Nutr. 2020;111:708-718. doi.org/10.1093/ajcn/nqz332
12. Devries MC, Phillips SM. Creatine supplementation during resistance training in older adults: a meta-analysis. Med Sci Sports Exerc. 2014;46:1194-1203. doi.org/10.1249/MSS.0000000000000220
13. Deutz NEP, et al. Effect of beta-hydroxy-beta-methylbutyrate (HMB) on lean body mass during 10 days of bed rest in older adults. Clin Nutr. 2013;32:704-712. doi.org/10.1016/j.clnu.2013.02.011
14. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24:1553-1564. doi.org/10.1111/dom.14725